Gabay Avraham 4
4 · ORAMED PHARMACEUTICALS INC. · Filed Sep 16, 2019
Insider Transaction Report
Form 4
Gabay Avraham
Chief Financial Officer
Transactions
- Disposition to Issuer
Stock Option (right to buy)
2019-06-17−33,146→ 0 totalExercise: $3.55Exp: 2029-06-17→ Common Stock (33,146 underlying) - Award
Stock Option (right to buy)
2019-09-12+33,146→ 33,146 totalExercise: $3.55Exp: 2029-09-12→ Common Stock (33,146 underlying)
Footnotes (1)
- [F1]The two reported transactions involved the cancellation of an outstanding option and the grant of a replacement option. The option was originally granted on June 17, 2019 and provides for vesting in 4 installments as follows: 5,396 shall vest on December 31, 2019; and 9,250 shall vest on each of December 31, 2020, December 31, 2021 and December 31, 2022.